5 nights in Chicago and a 5-year strategic plan for PF

The Pulmonary Fibrosis Foundation (PFF) Summit 2025 began for me with a nonstop flight from Washington, D.C., to Chicago during the longest government shutdown in the history of the U.S. I was resolved to be in Chicago for the summit, so I had backup plans that included taking the…

Treatment with Endeavor Biomedicines’ experimental oral therapy taladegib (ENV-101) improved lung function in people with idiopathic pulmonary fibrosis (IPF) in a Phase 2a clinical trial, newly published results show. “IPF has devastating effects on lung function, yet patients with this disease lack effective therapeutic options. Our Phase 2a…

The U.S. Food and Drug Administration (FDA) recently granted orphan drug designation to Calluna Pharma‘s CAL101 as a potential treatment for idiopathic pulmonary fibrosis (IPF).  This designation is intended to incentivize the development of treatments for rare diseases that affect fewer than 200,000 people…

“Ready to get that tube out? Sam, are you ready to get that tube out? Are you in any pain? No. Are you ready to breathe on your own?” Those were among the first words I heard as my wife, Susan, sat at my bedside while my care team brought…

Less than a year after my husband, Donnie, was diagnosed with pulmonary fibrosis, we decided to take a road trip to the suburbs of Denver to attend a memorial service for a close family friend. His family had invited us to stay for a few days, and we decided…

Blocking caspase-9 — an enzyme involved in programmed cell death, or apoptosis — may halt or reverse tissue scarring in pulmonary fibrosis (PF), according to a new preclinical study. Researchers found elevated levels of caspase-9 in lung tissue from people with PF and in a mouse model of the…

Water is essential to life. As UC Davis Health notes, it’s “vital to our health. It plays a key role in many of our body’s functions, including bringing nutrients to cells, getting rid of wastes, protecting joints and organs, and maintaining body temperature.” However, the source of the water we…

Software that uses artificial intelligence to analyze medical imaging tests may help facilitate earlier diagnosis and more accurate monitoring of pulmonary fibrosis in people with underlying lung diseases. Brainomix‘s e-Lung could allow doctors to detect progressive pulmonary fibrosis (PPF), where lung tissue becomes increasingly scarred and leads to…

For the first time in more than 10 years, idiopathic pulmonary fibrosis (IPF) care teams and patients will have a new treatment option following the Oct. 7 approval of Jascayd (nerandomilast) by the U.S. Food and Drug Administration (FDA). When I was diagnosed with IPF in January 2017,…